Cancer Nanotechnology (Jul 2023)
Correction: Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluation
Abstract
No abstracts available.